Interleukin-12 augments cytolytic activity of peripheral and decidual lymphocytes against choriocarcinoma cell lines and primary culture human placental trophoblasts

American Journal of Reproductive Immunology

Volumn 41, Issue 5, 1999, Pages 320-329

  Hayakawa, Satoshi ^a,b   Nagai, Nobuhisa ^a   Kanaeda, Takashi ^a   Karasaki Suzuki, Miki ^a   Ishii, Maki ^a   Chishima, Fumihisa ^a   Satoh, Kazuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Choriocarcinoma; Cytotoxicity; IL 12; Trophoblast

Indexed keywords

CYTOTOXIC FACTOR; FAS LIGAND; INTERLEUKIN 12; INTERLEUKIN 2; LACTATE DEHYDROGENASE; MESSENGER RNA; PERFORIN; SERINE PROTEINASE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DECIDUA; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST;

EID: 0033055433     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1999.tb00445.x     Document Type: Article

References (46)

1. King A, Birkby C, Loke YW: Early human decidual cells exhibit NK activity against K562 line but not against first trimester trophoblast. Cell Immunol 1989; 118:337-344.
2. Burt D, Johnson D, DeWitt TR, Elsen PV, Stern PL: Cellular immune recognition of HLA-G expressing choriocarcinoma cell line JEG-3. Int J Cancer Suppl 1991: 6:117-122.
3. Ellis SA, Sargent IL, Redman CWG, McMichael AJ: Evidence for a novel HLA antigen found on human extravillous trophoblast and choriocarcinoma cell line. Immunology 1986; 59:595-601.
4. Stern PL, Beresford NA, Friedman CI, Stevens VC, Risk JM, Johnson PM: Class-I like MHC molecules expressed by baboon placental syncytiotrophoblast. J Immunol 1987; 138:1088-1091.
5. Kovats S, Main EK, Librach C, Sttablebine M, Fisher SJ, Demars R: A class-I antigen HLA-G expressed in human trophoblasts. Science 1990; 248:220-223.
6. Denitz G, Christmas SE, Brew R, Johnson PM: Phenotypic and functional cellular differences between human CD3 decidual and peripheral blood lymphocytes. J Immunol 1994; 152:4255-4261.
7. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274(5288):792-795.
8. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:370-375.
9. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345(8961):1340-1342.
10. Chao KH, Yang YS, Ho HN, Chen SU, Chen HF, Dai HJ. Huang SC, Gill III TJ: Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am J Reprod Immmunol 1995; 34:274-280.
11. Gafter U, Sredni B, Segal J, Kalechman Y: Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogenic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997; 17:408-419.
12. Ferry BL, Sargent IL, Starkey PM, Redman CWG: Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from early pregnancy decidua. Cell Immunol 1991; 132:140-149.
13. King A, Loke YW: Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual NK cells. Cell Immunol 1990; 122:435-448.
14. Abadia-Molina A, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J Reprod Immunol 1996; 31:109-123.
15. Shiraishi H, Hayakawa S, Satoh K: Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic lymphocytes and placental apoptosis. J Clin Lab Immunol 1996; 48:93-108.
16. Thai NL, Li Y, Fu F, Qian S, Demetris AJ, Duquesnoy RJ, Fung JJ: Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg 1997; 3:118-129.
17. Gately MK, Gubler U, Brunda MJ, Nadeau RR, Anderson TD, Lipman JM, Sarminento U: Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Therapeutic Immunol 1994; 1:187-196.
18. Kumagai K, Takeda K, Hashimoto W, Seki S, Ogasawara K, Anzai R, Takahashi M, Sato M, Rikiishi H: Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity. Int Rev Immunol 1997; 14:229-256.
19. Fujiwara H, Hamaoka T: Antitumor and antimetastatic effects of interleukin 12. Cancer Chemother Pharmacol Suppl 1996; 38:S22-S26.
20. Vitale A, Guarini A, Latagliata R, Cignetti A, Foa R: Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukemia blasts. Br J Haematol 1998; 101:150-157.
21. Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY: Interleukin-12 synergies with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. J Soc Gynecol Investig 1995; 2:762-771.
22. Korzeniewski C, Callewaert DM: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64:313-320.
23. Konjevic G, Jurisic V, Spuzic I: Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cytotoxicity. J Immunol Methods 1997; 200:199-201.
24. Lipman ML, Stevens AC, Bleackley RC, Helderman JH, McCune TR, Harmon WE, Shapiro ME, Rosen S, Strom TB: The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53:73-79.
25. Lipman ML, Stevens AC, Strom TB: Heightened intraaraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152:5120-5127.
26. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T: Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204:468-474.
27. Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, Roach AG, Werstwick J, Williams RJ: Human vascular smooth muscle cells express receptors for CC chemokine. Arteriovasculer Thromb Vas Biol 1998; 18:397-403.
28. Yamada H, Polgar K, Hill JA: Cell-mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 170(5.1):1339-1344.
29. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1984; 65:55-63.
30. Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, Ichijo M, Kurahayashi M, Sugamura K: Accumulation of CD16-CD56 bright natural killer cells with high affinity interleukin2 receptors in human early pregnancy decidua. Int Immunol 1991; 3:743-750.
31. Starky PM, Sargent IL, Redman CWJ: Cell populations in human early pregnant decidua: Characterization and isolation of large granular lymphocytes by flow cytometry. Immunol 1988; 65:129-134.
32. Lamont AG, Andrini L: IL-12: a key cytokine in immune regulation. Immunol Today 1996; 17:214-217.
33. Wegman TG, Hui Lin, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship; is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
34. Hui Lin, Mosmann TR, Guilbert L, Tuntiopipat S, Wegman TG: Synthesis of T helper 2 type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
35. Hill JA, Polger K, Anderson DJ: T helper 1 type immunity to trophoblasts in women with recurrent spontaneous abortion. JAMA 1995; 2/3:1933-1936.
36. Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M: Elevations of serum IL-12 concentrations in women with severe preeclampsia and HELLP syndrome. J Reprod Immunol 1996; 31:97-107.
37. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Fait G, Wolman I, Lessing JB: Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol 1998; 39:376-380.
38. Hayakawa S, Fujikawa T, Karasaki-Suzuki M, Nemoto N, Sakurai S, Satoh K: submitted.
39. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J: Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 1993; 82:2790-2796.
40. Rossi AR, Pericle F, Rashleigh S, Janiec J, Djeu Y: Lysis of Neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood 1994; 83:1323-1328.
41. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G: Cooperation of natural killer cell stimulatory factor/Interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 1994; 156:480-492.
42. Cesano A, Visonneau S, Clark SC, Santoli D: Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 1993; 151:2943-2957.
43. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET: IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 1995; 165:33-43.
44. + T cells in IL-12-induced immune responses in vivo. J Immunol 1998; 160:16-19.
45. Hayakawa S, Saito S, Nemoto N, Chishima F, Akiyama K, Shiraishi H, Hayakawa J, Karasaki-Suzuki M, Fujii TK, Ichijo M, Sakurai I, Satoh K: Expression of recombinase activationgenes(RAG-1,2) in human decidual mononuclear cells. J Immunol 1994; 153:4934-4939.
46. Kimura M, Hanawa H, Watanabe H, Ogawa M, Abo T: Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell Immunol 1995; 162:16-25.